CDISC Therapeutic Area Data Standards: User Guide for Breast Cancer (Version 1.0) Â© 2016 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 3 Provisional May 16, 2016 APPENDIX F: REFERENCES ................................ ................................ ................................ ................................ ........... 65 Appendix F1: Works Cited ................................ ................................ ................................ ................................ ...... 65 Appendix F2: Further Reading ................................ ................................ ................................ ................................ 67 APPENDIX G: REPRESENTATIONS AND WARRANTIES , LIMITATIONS OF LIABILITY , AND DISCLAIMERS ....................... 68 FIGURE S Figure 1: Concept Classification Key for Concept Maps ................................ ................................ .............................. 6 Figure 2: Visual Presentation of Non -Standard Variables in This Document ................................ ............................... 7 Figure 3: Treatment Settings in Breast Cancer ................................ ................................ ................................ .............. 8 CONCEPT MAPS Concept Map 1: Initial Diagnosis of Breast Cancer ................................ ................................ ................................ .... 11 Concept Map 2: Breast Cancer Staging ................................ ................................ ................................ ....................... 12 Concept Map 3: Removal of Cancer Tissue ................................ ................................ ................................ ................ 13 Concept Map 4: Treatment of Breast Cancer ................................ ................................ ................................ .............. 27 Concept Map 5: Recurrence of Breast Cancer ................................ ................................ ................................ ............. 41 TABLES Table 3.3.1: Molecular Measurements ................................ ................................ ................................ ........................ 14 Table 3.3.2: Cancer Measurements ................................ ................................ ................................ .............................. 15 Table 3.3.3: Primary Tumor Grade Assessments ................................ ................................ ................................ ........ 16 Table 3.3.4: Pre -specified Findings ................................ ................................ ................................ ............................. 17 Table 3.3.5: Genetic/Molecular Analysis ................................ ................................ ................................ .................... 17 Table 3.3.6: Histologic/Morphologic/Molecular Types of Breast Cancer ................................ ................................ ... 18 Table 5.2.1: Categorical Analysis of Tumor Response ................................ ................................ ............................... 51 Table 5.2.2: Analysis of Time to Progression ................................ ................................ ................................ .............. 51 SAMPLE CRFS Annotated CRF: Radiation Therapy ................................ ................................ ................................ ............................ 23 Annotated CRF: Tumor Identification/Results Target Lesions ................................ ................................ ................... 31 Annotated CRF: Tumor Identification/Results Non -Target Lesions ................................ ................................ ........... 32 Annotated CRF: Tumor Identification/Results New Lesions ................................ ................................ ...................... 33 Annotated CRF: Disease Response ................................ ................................ ................................ ............................. 35